{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:49:34Z","timestamp":1787852974822,"version":"build-2784847793"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR13738\/MED\/15\/37\/2010"],"award-info":[{"award-number":["BT\/PR13738\/MED\/15\/37\/2010"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.02644","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T13:34:09Z","timestamp":1515591249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo"],"prefix":"10.3389","volume":"8","author":[{"given":"Rahul","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi K.","family":"Rajpoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Poddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathyamangalam","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.","volume":"6","author":"Balsitis","year":"2010","journal-title":"PLOS Pathog."},{"key":"B2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jbiosc.2010.05.001","article-title":"Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris.","volume":"110","author":"Batra","year":"2010","journal-title":"J. Biosci. Bioengg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue.","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1128\/JVI.01190-10","article-title":"Genotype-specific neutralization and protection by antibodies against dengue virus type 3.","volume":"84","author":"Brien","year":"2010","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001188","article-title":"In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection.","volume":"5","author":"De Alwis","year":"2011","journal-title":"PLOS Negl. Trop. Dis."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004386","article-title":"Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.","volume":"10","author":"De Alwis","year":"2014","journal-title":"PLOS Pathog."},{"key":"B8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans.","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1586\/erv.10.159","article-title":"Unique challenges faced by the clinical evaluation of dengue vaccines.","volume":"10","author":"Edelman","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1126\/science.aaf9590","article-title":"Benefits and risks of the Sanofi-Pasteur dengue vaccine: modeling optimal deployment.","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.4269\/ajtmh.2012.12-0157","article-title":"The economic burden of dengue.","volume":"86","author":"Gubler","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease.","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody dependent enhancement of dengue viruses.","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine.","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.","volume":"31","author":"Henchal","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4269\/ajtmh.16-0503","article-title":"Recombinant dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies.","volume":"96","author":"Khetarpal","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization.","volume":"45","author":"Kraus","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1128\/CVI.00087-10","article-title":"Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.","volume":"17","author":"Kuwahara","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1128\/JCM.43.7.3267-3272.2005","article-title":"Flow cytometry-based assay for titrating dengue virus.","volume":"43","author":"Lambeth","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"B21","first-page":"712","article-title":"\u201cFlaviviridae,\u201d in","author":"Lindenbach","year":"2013","journal-title":"Fields Virology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11262-009-0418-2","article-title":"Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.","volume":"40","author":"Liu","year":"2010","journal-title":"Virus Genes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064595","author":"Mani","year":"2013","journal-title":"Pichia pastoris"},{"key":"B24","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.vaccine.2015.09.101","article-title":"Preclinical and clinical development of a dengue recombinant subunit vaccine.","volume":"33","author":"Manoff","year":"2015","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: an integrated view.","volume":"22","author":"Martina","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein.","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15674","article-title":"Zika virus pathogenesis in rhesus monkeys is unaffected by pre-existing immunity to dengue virus.","volume":"8","author":"Pantoja","year":"2017","journal-title":"Nat. Commun."},{"key":"B28","first-page":"747","article-title":"\u201cFlaviviruses,\u201d in","author":"Pierson","year":"2013","journal-title":"Fields Virology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-016-0280-y","article-title":"Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.","volume":"16","author":"Poddar","year":"2016","journal-title":"BMC Biotechnol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000718","article-title":"Immature dengue virus: a veiled pathogen?","volume":"6","author":"Rodenhuis-Zybert","year":"2010","journal-title":"PLOS Pathog."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000823","article-title":"The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.","volume":"6","author":"Shrestha","year":"2010","journal-title":"PLOS Pathog."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc Loop of domain II of the envelope protein.","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"B34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/JVI.01805-15","article-title":"Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site.","volume":"90","author":"Smith","year":"2016","journal-title":"J. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1128\/JVI.06335-11","article-title":"Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.","volume":"86","author":"Smith","year":"2012","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J. Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1128\/JVI.01314-13","article-title":"Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.","volume":"87","author":"Sukupolvi-Petty","year":"2013","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1016\/j.vaccine.2015.08.090","article-title":"Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells.","volume":"33","author":"Suphatrakul","year":"2015","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/13543771003767476","article-title":"Dengue vaccines: state of the art.","volume":"20","author":"Swaminathan","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"B40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1473-3099(13)70028-8","article-title":"Dengue vaccine efficacy trial: Does interference cause failure?","volume":"13","author":"Swaminathan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jviromet.2011.01.001","article-title":"A highly sensitive and specific time resolved fluorometric bridge assay for antibodies to HIV-1 and -2.","volume":"173","author":"Talha","year":"2011","journal-title":"J. Virol. Methods"},{"key":"B42","first-page":"1986","article-title":"Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.","volume":"125","author":"Tang","year":"2012","journal-title":"Chin. Med. J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/infdis\/jiq060","article-title":"The necessity and quandaries of dengue vaccine development.","volume":"203","author":"Thomas","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01005","author":"Tripathi","year":"2015","journal-title":"Pichia pastoris"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7091","DOI":"10.1016\/j.vaccine.2015.09.053","article-title":"Next generation dengue vaccines: a review of the preclinical development pipeline.","volume":"33","author":"Vannice","year":"2015","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America.","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000821","article-title":"Natural strain variation and antibody neutralization of dengue serotype 3 viruses.","volume":"6","author":"Wahala","year":"2010","journal-title":"PLOS Pathog."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008325","article-title":"Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.","volume":"4","author":"Wang","year":"2009","journal-title":"PLOS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice.","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"key":"B50","year":"2017","journal-title":"Dengue and Dengue Haemorrhagic Fever. Factsheet No117."},{"key":"B51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease.","volume":"7","author":"Zellweger","year":"2010","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T15:30:01Z","timestamp":1526398201000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.02644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":51,"alternative-id":["10.3389\/fmicb.2017.02644"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.02644","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]},"article-number":"2644"}}